Browsing HLS Student Papers by Title
Now showing items 188-207 of 498
-
From Regulation to Litigation: An Analysis of the Silicone Breast Implant Controversy
(2000)At the age of eighteen, Britney Spears has reached superstar status. She has sold millions of albums, and her music videos are among MTV's most popular. Teenage boys idolize her, and teenage girls strive to look like her. ... -
From the Farm to the Factory: An Overview of the American and European Approaches to Regulation of the Beef Industry
(2004)This paper gives a brief overview of the American and European approaches to regulation of the beef industry. First, it outlines the legal frameworks in both the United States and the European Union. Secondly, the paper ... -
Gene Therapy: Cure or Poison? The Proper Role of the FDA in the Bubble Boy Disease Question
(2004)On January 14, 2003, the Food and Drug Administration “suspended 27 gene therapy trials involving several hundred patients after learning that a second child treated in France had developed a condition ... -
Genesis: The Birth of the FDA in the Patent Office
(1999)The FDA did not take its current form until 1938. Prior to that it had gone through a period in which its power and purpose evolved as the needs and desires of the American public changed. In this paper, I seek to trace ... -
Genetic Testing and Government Regulation: The Growing Significance of Pharmacogenomics
(2003)Genetic testing, currently a diagnostic tool used by only a small fraction of the population, promises to become a routine and critical part of medical care and drug prescription in the near future. This change will come ... -
Gently Down the Stream: How Exploding Steamboat Boilers in the 19th Century Ignited Federal Public Welfare Regulation [REDACTED VERSION]
(2002)Boiler explosions plagued the steamboat industry during the early years of its existence (1816-1852), costing thousands of lives and prompting the federal government to enact private welfare regulation for the first time. ... -
GHB’s Path to Legitimacy: An Administrative and Legislative History of Xyrem
(2004)This paper traces the path of a chemical compound (gamma-hydroxybutyrate, or GHB) from its status as an abused street drug to that of a legitimate, life-altering prescription treatment for a debilitating condition. It ... -
Giving You Wings: Should the Food and Drug Administration Investigate the Safety of Red Bull and So-Called Energy Drinks?
(2003)Discussion of potential FDA regulation of energy drinks such as Red Bull. -
Glamorization or Condemnation: The Accuracy of Hollywood’s Portrayal of Heroin Use in Motion Pictures in the 1990’s
(2004)The United States saw a dramatic increase in heroin use during the 1990’s. During that same time, heroin references in popular music, movies, and fashion became increasingly common. This paper seeks to ... -
Government Regulation of Off-Label Drug Prescriptions: Balancing Healthcare Innovation with Public Safety and Fiscal Responsibility
(2004)This paper examines the government’s role in regulating off-label drug prescriptions, both as a patient safety advocate and as a health insurer. Part One describes why off-label drug prescriptions occur, ... -
Greening the Blue Revolution: How History Can Inform a Sustainable Aquaculture Movement
(2014-03-18)This Paper traces the history of aquaculture from ancient China until the present, highlighting the various degrees of, and reasons for, aquaculture’s popularity at different points throughout history. The history of ... -
The H2 Blockers' Rx-to OTC Switch: For Whom Will It Spell Relief?
(1995)Tylenol. Advil. Monistat 7. Imodium AD. These are some of the most commonly used, widely available, and successful drugs in the United States. All of them began as drugs only available by a prescription. All of them made ... -
Happy Inconsistency: Health Claims Standards at the FTC and FDA
(1997)We live in a society increasingly preoccupied with healthy food. Restaurant menus now include "heart smart" options, network news programs run segments on teenage vegetarians, consumer groups denounce our beloved movie ... -
Harmonizing Pharmaceutical Regulation Among the United States, the European Union, and Japan: The ICH Initiative
(2003)The United States, the European Union and Japan comprise 75% of the world's pharmaceutical market and generate 90% of all pharmaceutical research. Recognizing the need for and benefits of harmonized testing standards the ... -
Harvey Wiley, Theodore Roosevelt, and the Federal Regulation of Food and Drugs
(2004)The Roosevelt and Wiley story is important because it shows the role individuals can have on the course of history. Congressional passage of the Food and Drug Act, as well as the Meat Inspection Act, reflected sweeping ... -
The Hatch-Waxman (Im)Balancing Act
(2003)The Hatch-Waxman Act was intended to establish a balance between the competing interests of brand name and generic drug companies, fostering innovation while giving the public access to a wider selection of affordable ... -
Health Care Fraud Liability for Pharmaceutical Manufacturers
(2011)Fraud is an increasingly expensive cost to the health care industry, and the regulatory and prosecutorial focus during the fast few decades have focused on health care fraud by pharmaceutical manufacturers. This paper ... -
Health Effects & Wine: The FDA Should Regulate the Health Effects on Wine Labels
(2002)In 1976, the District Court of the Western District of Kentucky, in Brown-Forman Distillers Corp. v. Matthews, found that alcoholic beverages were exempt from the Food & Drug Administration labeling requirements. Since ... -
A Heavy Burden: Rethinking the F.D.A.’s Safety Balancing in the Evaluation of Weight Loss Medications
(2011)The Food and Drug Administration has recently rejected three drugs for the treatment of obesity based on safety concerns, engendering debate about the standards the Agency should use in evaluating weight loss medications. ... -
Herbs and the FDA: Current Regulation, Problems and Suggestions for Change
(2002)In this paper, I will discuss the current treatment of herbal products under DSHEA and describe some of the risks of herbal products. I will also talk about current FDA responses to these risks and provide some suggestions ...